Lympha Press® Clinical Spotlight: Breast Cancer Related Lymphedema

Breast Cancer–Related Lymphedema: Know the Risk

Breast cancer–related lymphedema is a recognized long-term complication of breast cancer treatment. It develops when the lymphatic system is disrupted, most commonly due to surgery or radiation that affects lymph nodes responsible for draining fluid from the breast, chest, and arm.

When Does Lymphedema Most Often Occur?

According to The Journal of Clinical Oncology, up to 90% of lymphedema cases occur within three years after breast cancer treatment. This period represents the highest-risk window, yet symptoms may appear gradually and are sometimes overlooked during recovery and survivorship care.

How Common Is Lymphedema After Breast Cancer?

Clinical studies show that approximately 1 in 3 breast cancer survivors develops lymphedema at some point following treatment. Despite this prevalence, research indicates that nearly half of affected individuals report they were never informed about their risk, limiting opportunities for early recognition and management.

Why Breast Cancer Treatment Increases Risk

Breast cancer treatments such as sentinel lymph node biopsy, axillary lymph node dissection, and regional radiation can damage or remove lymph nodes that normally regulate lymphatic fluid flow. When these pathways are altered, lymph fluid can accumulate in surrounding tissues, leading to swelling, discomfort, and changes in function.

Long-Term Impact on Daily Life

Lymphedema is not only a cosmetic or transient issue. Evidence shows that up to 40% of individuals with breast cancer–related lymphedema report chronic pain or functional limitations, which may affect mobility, work, and overall quality of life.

The Importance of Early Awareness and Management

Early awareness, patient education, and ongoing monitoring are considered essential components of lymphedema care. Identifying risk factors and addressing symptoms early may help limit progression and support long-term function.

The Role of Compression Therapy

Lympha Press® compression therapy is designed to support the management of breast cancer–related lymphedema through controlled, sequential pneumatic compression. When used as part of a comprehensive care plan and under medical guidance, compression therapy may assist lymphatic fluid movement, support mobility, and contribute to long-term symptom management in both clinical and home settings.

Sources

• The Journal of Clinical Oncology – Incidence and time to onset of breast cancer–related lymphedema

• DiSipio T, et al. Incidence of unilateral arm lymphedema after breast cancer: a systematic review

• International Lymphoedema Framework (ILF) – Lymphedema prevalence and survivorship considerations

• National Cancer Institute (NCI) – Breast cancer treatment–related lymphatic complications